Back
Acumen Pharmaceuticals Stock Price Chart
Sponsored
ABOS
Sponsored
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1
ABOS
Acumen Pharmaceuticals
Last Price:
$1.88
Seasonality Move:
-11%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight selling pressure.
Acumen Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.79 | Sell |
20-day SMA: | 1.98 | Sell |
50-day SMA: | 2.4 | Sell |
200-day SMA: | 2.83 | Sell |
8-day EMA: | 1.81 | Sell |
20-day EMA: | 1.97 | Sell |
50-day EMA: | 2.23 | Sell |
200-day EMA: | 2.8 | Sell |
Acumen Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 31.98 | Sell |
Chaikin Money Flow: | -134695 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.83 - 2.25) | Sell |
Bollinger Bands (100): | (2.12 - 2.82) | Sell |
Acumen Pharmaceuticals Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Acumen Pharmaceuticals Stock
Is Acumen Pharmaceuticals Stock a Buy?
-
Acumen Pharmaceuticals share price is 1.72 while ABOS 8-day simple moving average is 1.79, which is a Sell signal.
-
The stock price of ABOS is 1.72 while Acumen Pharmaceuticals 20-day SMA is 1.98, which makes it a Sell.
-
Acumen Pharmaceuticals 50-day simple moving average is 2.40 while ABOS share price is 1.72, making it a Sell technically.
-
ABOS stock price is 1.72 and Acumen Pharmaceuticals 200-day simple moving average is 2.83, creating a Sell signal.
ABOS Technical Analysis vs Fundamental Analysis
Sell
1
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy or a Sell?
-
Acumen Pharmaceuticals stock is rated a SellThe current Acumen Pharmaceuticals [ABOS] share price is $1.72. The Score for ABOS is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Acumen Pharmaceuticals Stock Info
Market Cap:
103.3M
Price in USD:
1.72
Share Volume:
269.4K
Acumen Pharmaceuticals 52-Week Range
52-Week High:
5.09
52-Week Low:
1.69
Sell
1
Acumen Pharmaceuticals (ABOS)
is a Sell
Acumen Pharmaceuticals Share Price Forecast
-
What is the Acumen Pharmaceuticals stock price today?The Acumen Pharmaceuticals stock price is 1.72 USD today.
-
Will ABOS stock go up or go down?Acumen Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Acumen Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acumen Pharmaceuticals is overvalued.
Is Acumen Pharmaceuticals Stock a Buy?
-
Acumen Pharmaceuticals share price is 1.72 while ABOS 8-day exponential moving average is 1.81, which is a Sell signal.
-
The stock price of ABOS is 1.72 while Acumen Pharmaceuticals 20-day EMA is 1.97, which makes it a Sell.
-
Acumen Pharmaceuticals 50-day exponential moving average is 2.23 while ABOS share price is 1.72, making it a Sell technically.
-
ABOS stock price is 1.72 and Acumen Pharmaceuticals 200-day simple moving average is 2.80, creating a Sell signal.
Fundamental Analysis of Acumen Pharmaceuticals
Is Acumen Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Acumen Pharmaceuticals
Should I short Acumen Pharmaceuticals stock?
-
ABOS Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Acumen Pharmaceuticals is a Sell
-
Acumen Pharmaceuticals Relative Strength Index (RSI) is 31.98, which suggest Acumen Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Acumen Pharmaceuticals is (1.83 - 2.25), which suggest Acumen Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Acumen Pharmaceuticals is (2.12 - 2.82), which suggest Acumen Pharmaceuticals is a Sell
* Acumen Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.